<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2504221977
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2010
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        DESLOR 5 MG FILM COATED TABLET
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        DESLORATADINE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        mg
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Film-coated tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        20
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Blister
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        OTC
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        do not store above 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        23.3
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Jamjoom Pharmaceuticals Factory Company" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Jamjoom Pharmaceuticals Factory Company
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 394]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            JAMJOOM PHARMACEUTICALS CO. LTD.
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            Jamjoom Pharmaceuticals Factory  Company
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        R06AX27
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Deslor&trade; is an anti-allergy medicine that does not make you<br />drowsy. It helps control your allergic reaction and its symptoms.<br />Deslor&trade; relieves symptoms associated with allergic rhinitis<br />(inflammation of the nasal passages caused by an allergy, for<br />example, hay fever or allergy to dust mites). These symptoms<br />include sneezing, runny or itchy nose, itchy palate, and itchy, red or<br />watery eyes.<br />Deslor&trade; is also used to relieve the symptoms associated with<br />urticaria (a skin condition caused by an allergy). These symptoms<br />include itching and hives.<br />Relief of these symptoms lasts a full day and helps you to resume<br />your normal daily activities and sleep.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Do not take Deslor&trade;<br />- if you are allergic (hypersensitive) to desloratadine, to any of the<br />other ingredients of Deslor&trade; or to loratadine.<br />Deslor&trade; is indicated for adults and adolescents (12 years of age<br />and older).<br />Take special care with Deslor&trade;<br />- if you have poor kidney function.<br />If this applies to you, or if you are not sure, please check with your<br />doctor before taking Deslor&trade;.</p><p>Taking other medicines<br />There are no known interactions of Deslor&trade; with other medicines.<br />Taking Deslor&trade; with food and drink<br />Deslor&trade; may be taken with or without a meal.<br />Pregnancy and breast-feeding<br />Ask your doctor or pharmacist for advice before taking any<br />medicine during pregnancy and breast-feeding.<br />If you are pregnant or nursing a baby, taking Deslor&trade; is not<br />recommended.<br />Driving and using machines<br />At the recommended dose, Deslor&trade; is not expected to cause you<br />to be drowsy or less alert. However, very rarely some people<br />experience drowsiness, which may affect their ability to drive or<br />use machines.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Adults and adolescents (12 years of age and older): take one tablet<br />once a day.<br />Swallow the tablet whole with water, with or without food.<br />Regarding the duration of treatment, your physician will determine<br />the type of allergic rhinitis you are suffering from and will<br />determine for how long you should take Deslor&trade;.<br />If your allergic rhinitis is intermittent (presence of symptoms for<br />less than 4 days per week or for less than 4 weeks), your physician<br />will recommend you a treatment schedule that will depend on the<br />evaluation of the history of your disease.<br />If your allergic rhinitis is persistent (presence of symptoms for 4<br />days or more per week and for more than 4 weeks), your physician<br />may recommend you a longer term treatment.<br />For urticaria, the duration of treatment may be variable from<br />patient to patient and therefore you should follow the instructions<br />of your physician.<br />If you take more Deslor&trade; than you should<br />Take Deslor&trade; only as it is prescribed for you. No serious<br />problems are expected with accidental overdose. However, if you<br />take more Deslor&trade; than you were told to, contact your doctor or<br />pharmacist.<br />If you forget to take Deslor&trade;<br />If you forget to take your dose on time, take it as soon as possible,<br />then go back to your regular dosing schedule. Do not take a double<br />dose to make up for a forgotten dose.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, Deslor&trade; can cause side effects, although not<br />everybody gets them. In adults, side effects were about the same as<br />with a dummy tablet. However, fatigue, dry mouth and headache<br />were reported more often than with a dummy tablet. In<br />adolescents, headache was the most commonly reported side<br />effect.<br />During the marketing of desloratadine, cases of severe allergic<br />reactions (difficulty in breathing, wheezing, itching, hives and<br />swelling) and rash have been reported very rarely. Cases of<br />palpitations, rapid heartbeat, stomach pain, nausea (feeling sick),<br />vomiting, upset stomach, diarrhoea, dizziness, drowsiness,<br />inability to sleep, muscle pain, hallucinations, seizures, restlessness<br />with increased body movement, liver inflammation and abnormal<br />liver function tests have also been reported very rarely.<br />If any of the side effects gets serious, or if you notice any side<br />effects not listed in this leaflet, please tell your doctor or<br />pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the reach and sight of children.<br />Do not store above 30 &ordm;C. Store in a dry place.<br />Do not use Deslor&trade; after the expiry date which is stated on the<br />carton and blister.<br />Tell your pharmacist if you notice any change in the appearance of<br />the tablets.<br />Medicines should not be disposed of via wastewater or household<br />waste. Ask your pharmacist how to dispose of medicines no longer<br />required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>What Deslor&trade; contains<br />- The active substance is desloratadine 5 mg.<br />- The other ingredients are Crospovidone, Dibasic calcium<br />phosphate dihydrate, Magnesium stearate, Maize starch,<br />Microcrystalline cellulose, Opadry white, Propylene glycol, Talc<br />and Purified water.<br />&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                What Deslor™ looks like and contents of the pack
- Deslor™ 5 mg tablets are Off white to pinkish, round, biconvex
film coated tablets engraved with 'JP83' on one side and plain on
the other side.
- Deslor™ 5 mg tablets are available in the box of 20 film-coated
tablets.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Marketing Authorisation Holder and Manufacturer<br />Jamjoom Pharmaceuticals Co., Jeddah, Saudi Arabia.<br />Tel: +966-12-6081111, Fax: +966-12-6081222.<br />Website: www.jamjoompharma.com<br />To report any side effect(s):<br />&bull; Saudi Arabia:<br />- The National Pharmacovigilance and Drug Safety Centre (NPC)<br />o Fax: +966-11-205-7662<br />o Call NPC at +966-11-2038222<br />Exts: 2317-2356-2353-2354-2334-2340.<br />o Toll free phone: 8002490000<br />o E-mail: npc.drug@sfda.gov.sa<br />o Website: www.sfda.gov.sa/npc<br />&bull; Other GCC States:<br />&minus; Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                08/2015
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p>و دواء مضاد للحساسية لا يسبب لك النعاس. إنه يساعد &trade; ديسلور<br />على التحكم في التفاعلات التحسسية واعراضها.<br />من أعراض الْتِهابُ الأَنْفِ الأَرَجِيُّ &quot;التحسسي&quot; و هو &trade; يخفف ديسلور<br />التهاب للقناة الأنفية الناتج عن الحساسية مثل حمى القش أو الحساسية<br />تجاه عُثَّة الغبار. و تشمل تلك الأعراض العطس ورشح أو حكة بالأنف<br />وحكة بالحلق و حكة أو احمرار او تدميع بالعين.<br />أيضاً للتخفيف من أعراض الأرتيكاريا و هي حالة &trade; يستخدم ديسلور<br />تصيب الجلد بسبب الحساسية. وتشمل تلك الأعراض الحكة وبثور.<br />التخلص من هذه الأعراض يستمر لمدة يوم كامل ويساعدك هذاعلى<br />استئناف الأنشطة اليومية المعتادة والنوم.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>۲. قبل أن تبدأ في استخدام ديسلور<br />:&trade; لا تستخدم ديسلور<br />- إذا كنت تعاني من حساسية مفرطة للديسلوراتادين أو لأي من مكونات<br />الأخرى أو لمادة اللوراتادين. &trade; ديسلور<br />للبالغين و المراهقين ( ۱۲ سنة فما فوق). &trade; - يوصَف ديسلور<br />:&trade; إتخذ احتياطات خاصة عند استخدام ديسلور<br />- إذا كنت تعاني من ضعف في وظائف الكلى. إذا كانت هذه الحالة<br />تنطبق عليك أو إذا كنت غير متأكد فينصح باستشارة طبيبك قبل استخدام<br />.&trade; ديسلور<br />إستخدام أدوية أخرى:<br />مع الأدوية الأخرى. &trade; لا يوجد تداخلات دوائية معروفة بين ديسل</p><p>الطعام و الشراب: &trade; تناول ديسلور<br />مع أو بدون الطعام. &trade; يمكن أن يؤخذ ديسلور<br />الحمل و الرضاعة الطبيعية:<br />إستشيري طبيبك أو الصيدلي قبل تناول أي دواء خلال فترة الحمل أو<br />الرضاعة الطبيعية. إذا كنت حاملاً أو تقومين بإرضاع طفلك رضاعة<br />.&trade; طبيعية فلا ينصح باستخدام ديسلور<br />القيادة و استخدام الآلات:<br />نعاس أو نقص في الإنتباه إذا أُخِذ في &trade; لا يُتوقع أن يسبب ديسلور<br />الجرعات المعتادة. ومع ذلك فإنه نادراً ما يعاني بعض الأشخاص من<br />نعاس و الذي يمكن أن يؤثر على مقدرتهم على القيادة وتشغيل الآلات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>- البالغين و المراهقين ( يبغ من العمر ۱۲ عاماً فما فوق) يأخذ قرص<br />واحد في اليوم.<br />- قم ببلع القرص بأكمله مع الماء، مع أو بدون الطعام. فيما يتعلق بمدة<br />العلاج، سوف يقوم الطبيب المعالج بتحديد نوع الْتِهابُ الأَنْفِ الأَرَجِيُّ<br />&quot;التحسسي&quot; الذي تعاني منه وسوف يحدد المدة اتي يجب أن تستمر<br />.&trade; عليها في العلاج بأقراص ديسلور<br />- إذا كانت حساسية الأنف التي تصيبك متقطعة (أي أن الأعراض تكون<br />موجودة لأقل من أربعة أيام في الأسبوع أو لأقل من أربعة أسابيع).<br />سوف يقوم طبيبك بعمل جدول للعلاج يعتمد على تقييم التاريخ المرضي<br />لحالتك.<br />- إذا كانت حساسية الأنف التي تصيبك مستديمة (أي أن الأعراض تكون<br />موجودة لمدة أربعة أيام أو أكثر في الأسبوع أو لأكثر من أربعة أسابيع)<br />فسوف ينصحك طبيبك بفترة علاج أطول.<br />- بالنسبة للأرتكاريا، قد تكون مدة العلاج متغيرة من مريض لآخر،<br />وبالتالي يجب اتباع تعليمات الطبيب المعالج.<br />بكية أكثر من اللازم: &trade; إذا تناولت ديسلور<br />تماماً كما هو موصوف لك من قبل الطبيب. لا &trade; قم بتناول ديسلور<br />يتوقع حدوث مشاكل خطيرة مع تناول جرعة زائدة عن طريق الخطأ.<br />ومع ذلك إذا أخذت كمية أكثر مما وُصِف لك فقم بالاتصال بطبيبك أو<br />الصيدلي.<br />:&trade; إذا نسيت أن تتناول ديسلور<br />إذا نسيت أن تتناول جرعتك في ميعادها، فقم بتناولها في أسرع وقت<br />ممكن ثم عُد إلى جدول جرعاتك المعتاد. لا تقم بتناول جرعة مضاعفة<br />لتعويض جرعة قد نسيتها.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p>٤. التأثيرات الجانبية المحتملة<br />في حدوث تأثيرات جانبية مثله في ذلك مثل &trade; يمكن أن يتسبب ديسلور<br />باقي الأدوية بالرغم من عدم تعرض كل الأشخاص لها.<br />في الأشخاص البالغين كانت التأثيرات الجانبية مثل تلك التي حدثت<br />عند تناول الأقراص الزائفة. تم الإبلاغ عن حدوث إرهاق و جفاف<br />بالفم وصداع بشكل أكثر مما حدث مع الأقراص الزائفة.<br />في المراهقين كان الصداع هو أكثر التأثيرات الجانبية التي تم الإبلاغ<br />عنها.<br />عند تسويق أقراص ديسلوراتادين تم الإبلاغ عن حدوث حالات<br />تفاعلات تحسسية غاية في الندرة (صعوبة في التنفس، أزيز، حكة،<br />بثور و تورم) وطفح جلدي.<br />تم الإبلاغ أيضاً عن حالات غاية في الندرة من الخفقان، وسرعة<br />ضربات القلب وآلام في المعدة والغثيان والتقيؤ واضطرابات المعدة<br />والإسهال والدوخة والنعاس وعدم القدرة على النوم وآلام في العضلات<br />والهلوسة، والتشنجات والأرق مع زيادة حركة الجسم والتهاب الكبد<br />وإضطرابات في نتائج اختبارات وظائف الكبد.<br />إذا لاحظت تحول أي من الآثار الجانبية إلى مرحلة أكثر حدة أو إذا<br />لاحظت ظهور آثار جانبية أخرى غير مدرجة في هذه النشرة يرجى<br />إخبار طبيبك أو الصيدلي بها.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>٥. طريقة تخزين ديسلور<br />- يحفظ بعيداً عن متناول ومرأى الأطفال.<br />م. &ordm; - يحفظ في درجة حرارة لا تزيد عن ۳۰<br />- يحفظ في مكان جاف.<br />بعد انتهاء تاريخ الصلاحية &trade; - لا تقم باستخدام أقراص ديسلور<br />المدون على العبوة الكرتونية و على الشريط .<br />- لا يتم التخلص من الأدوية عن طريق مياه الصرف أو النفايات<br />المنزلية. إسأل الصيدلي عن طريقة التخلص من الأدوية الغير مرغوب<br />فيها فسوف تساعد هذه الإجراءات على حماية البيئة.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p>ما هي مكونات ديسلور<br />&bull; المادة الفعالة هي ديسلوراتادين ٥ ملجم.<br />&bull; المكونات الأخرى هي كروسبوفيدون، هيدروجين فوسفات الكالسيوم<br />ثنائي الماء، ستيرات الماغنيسيوم، نشا الذرة، سليلوز دقيق التبلور،<br />أوبادرى أبيض، بروبيلين جليكول، تلك، و ماء منقي.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p><br />و ما هي محتويات العبوة &trade; كيف يبدو ديسلور<br />٥ ملجم أقراص لونها مائل للأبيض إلى وردى، مستديرة، &trade; - ديسلور<br />و مستوية علي &#39;JP ثنائية التحدب مغلفة محفورة علي جانب واحد &#39; 83<br />الجانب الآخر.<br />٥ ملجم متوفر في علبة تحتوي علي ۲۰ قرص مغلف. &trade; - ديس</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p>اسم وعنوان مالك رخصة التسويق و المصنع:<br />شركة مصنع جمجوم للأدوية، جدة، المملكة العربية السعودية.<br />+۹٦٦-۱۲- ۹٦٦ + فاكس: ٦۰۸۱۲۲۲ -۱۲- هاتف: ٦۰۸۱۱۱۱<br />www.jamjoompharma.com : الموقع الإلكتروني<br />للإبلاغ عن أي أثار جانبيه:<br />&bull; المملكة العربية السعودية:<br />- المركز الوطني للتيقظ و السلامة الدوائية<br />+۹٦٦-۱۱-۲۰٥- فاكس: ۷٦٦۲ o<br />للإتصال بالإدارة التنفيذية للتيقظ وإدارة الأزمات. o<br />+۹٦٦-۱۱- هاتف: ۲۰۳۸۲۲۲<br />۲۳٤۰-۲۳۳٤-۲۳٥٤-۲۳٥۳-۲۳٥٦- تحويلة: ۲۳۱۷<br />الهاتف المجاني: ۸۰۰۲٤۹۰۰۰۰ o<br />npc.drug@sfda.gov.sa : بريد إلكتروني o<br />www.sfda.gov.sa/npc : الموقع الالكتروني o</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            08/2015
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Deslor 5 mg Film Coated Tablet
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each film coated tablet contains 5 mg Desloratadine.
For the full list of excipients, see section 6.1.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Film Coated Tablet, Oral.
Off-white to pinkish, round, about 6.0 mm in diameter, biconvex film coated tablets engraved with
'JP83' on one side and plain on the other side.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Desloratadine is indicated for the relief of symptoms associated with:<br />- Allergic rhinitis (see section 5.1),<br />- Urticaria (see section 5.1).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adults and adolescents (12 years of age and over)<br />The recommended dose of Desloratadine is one tablet once a day.<br />Intermittent allergic rhinitis (presence of symptoms for less than 4 days per week or for less than 4<br />weeks) should be managed in accordance with the evaluation of patient&#39;s disease history and the<br />treatment could be discontinued after symptoms are resolved and reinitiated upon their reappearance.<br />In persistent allergic rhinitis (presence of symptoms for 4 days or more per week and for more than 4<br />weeks), continued treatment may be proposed to the patients during the allergen exposure periods.<br />Paediatric population<br />There is limited clinical trial efficacy experience with the use of Desloratadine in adolescents 12<br />through 17 years of age (see sections 4.8 and 5.1).</p><p>The safety and efficacy of Desloratadine film-coated tablets in children under the age of 12 years<br />have not been established. No data are available.<br />Method of administration<br />Oral use.<br />The dose can be taken with or without food.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance, to any of the excipients listed in section 6.1 or to Loratadine.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>In the case of severe renal insufficiency, Desloratadine should be used with caution (see section 5.2).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No clinically relevant interactions were observed in clinical trials with Desloratadine tablets in which<br />erythromycin or ketoconazole were co-administered (see section 5.1).<br />Paediatric population<br />Interaction studies have only been performed in adults.<br />In a clinical pharmacology trial, Desloratadine tablets taken concomitantly with alcohol did not<br />potentiate the performance impairing effects of alcohol (see section 5.1). However, cases of alcohol<br />intolerance and intoxication have been reported during post-marketing use. Therefore, caution is<br />recommended if alcohol is taken concomitantly.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pregnancy Category C<br />Pregnancy<br />A large amount of data on pregnant women (more than 1,000 pregnancy outcomes) indicate no<br />malformative nor foeto/ neonatal toxicity of Desloratadine. Animal studies do not indicate direct or<br />indirect harmful effects with respect to reproductive toxicity (see section 5.3). As a precautionary<br />measure, it is preferable to avoid the use of Desloratadine during pregnancy.</p><p>Breast-feeding<br />Desloratadine has been identified in breastfed newborns/infants of treated women. The effect of<br />Desloratadine on newborns/infants is unknown. A decision must be made whether to discontinue<br />breast-feeding or to discontinue/abstain from Desloratadine therapy taking into account the benefit of<br />breast feeding for the child and the benefit of therapy for the woman.<br />Fertility<br />There are no data available on male and female fertility.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Desloratadine has no or negligible influence on the ability to drive and use machines based on clinical<br />trials.<br />Patients should be informed that most people do not experience drowsiness. Nevertheless, as there is<br />individual variation in response to all medicinal products, it is recommended that patients are advised<br />not to engage in activities requiring mental alertness, such as driving a car or using machines, until<br />they have established their own response to the medicinal product.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Summary of the safety profile<br />In clinical trials in a range of indications including allergic rhinitis and chronic idiopathic urticaria, at<br />the recommended dose of 5 mg daily, undesirable effects with Desloratadine were reported in 3 % of<br />patients in excess of those treated with placebo. The most frequent of adverse events reported in<br />excess of placebo were fatigue (1.2 %), dry mouth (0.8 %) and headache (0.6 %).<br />Pediatric Population<br />In a clinical trial with 578 adolescent patients, 12 through 17 years of age, the most common adverse<br />event was headache; this occurred in 5.9 % of patients treated with Desloratadine and 6.9 % of<br />patients receiving placebo.</p><p>Tabulated list of adverse reaction<br />The frequency of the clinical trial adverse reactions reported in excess of placebo and other undesirable<br />effects reported very rarely during the post-marketing period are listed in the following table.<br />Frequencies are defined as very common (&ge; 1/10), common (&ge; 1/100 to &lt; 1/10), uncommon (&ge;<br />1/1,000 to &lt; 1/100), rare (&ge; 1/10,000 to &lt; 1/1,000), and very rare (&lt; 1/10,000) and not known (cannot<br />be estimated from the available data).</p><p><img src="data:image/jpeg;base64,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" alt="" width="1054" height="1364" vspace="0" hspace="0" border="0" style="width:1054px;height:1364px;margin-top:0px;margin-bottom:0px;margin-left:0px;margin-right:0px;border:0px solid black;" /></p><p>&nbsp;</p><p>Paediatric population<br />Other undesirable effects reported during the post-marketing period in paediatric patients with an<br />unknown frequency included QT prolongation, arrhythmia, and bradycardia.<br />To report any side effect(s):<br />&bull; Saudi Arabia:<br />- The National Pharmacovigilance and Drug Safety Centre (NPC)<br />Fax: +966-11-205-7662<br />Call NPC at +966-11-2038222,<br />Exts: 2317-2356-2353-2354-2334-2340.<br />Toll free phone: 8002490000<br />E-mail: npc.drug@sfda.gov.sa<br />Website: www.sfda.gov.sa/npc</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>The adverse event profile associated with over dosage, as seen during post-marketing use, is similar<br />to that seen with therapeutic doses, but the magnitude of the effects can be higher.<br />Treatment<br />In the event of overdose, consider standard measures to remove unabsorbed active substance.<br />Symptomatic and supportive treatment is recommended.<br />Desloratadine is not eliminated by haemodialysis; it is not known if it is eliminated by peritoneal<br />dialysis.<br />Symptoms<br />Based on a multiple dose clinical trial, in which up to 45 mg of Desloratadine was administered<br />(nine times the clinical dose), no clinically relevant effects were observed.<br />Paediatric population<br />The adverse event profile associated with over dosage, as seen during post-marketing use, is similar<br />to that seen with therapeutic doses, but the magnitude of the effects can be higher.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: antihistamines &ndash; H1 antagonist, ATC code: R06A X27<br />Mechanism of action<br />Desloratadine is a non-sedating, long-acting histamine antagonist with selective peripheral H1<br />receptor antagonist activity. After oral administration, Desloratadine selectively blocks peripheral<br />histamine H1-receptors because the substance is excluded from entry to the central nervous system.<br />Desloratadine has demonstrated antiallergic properties from in vitro studies. These include inhibiting<br />the release of proinflammatory cytokines such as IL-4, IL-6, IL-8, and IL-13 from human mast<br />cells/basophils, as well as inhibition of the expression of the adhesion molecule P-selectin on<br />endothelial cells. The clinical relevance of these observations remains to be confirmed.<br />Clinical efficacy and safety<br />In a multiple dose clinical trial, in which up to 20 mg of Desloratadine was administered daily for<br />14 days, no statistically or clinically relevant cardiovascular effect was observed. In a clinical<br />pharmacology trial, in which Desloratadine was administered at a dose of 45 mg daily (nine times the<br />clinical dose) for ten days, no prolongation of QTc interval was seen.<br />No clinically relevant changes in Desloratadine plasma concentrations were observed in multipledose<br />ketoconazole and erythromycin interaction trials.<br />Desloratadine does not readily penetrate the central nervous system. In controlled clinical trials, at the<br />recommended dose of 5 mg daily, there was no excess incidence of somnolence as compared to<br />placebo. Desloratadine given at a single daily dose of 7.5 mg did not affect psychomotor performance<br />in clinical trials. In a single dose study performed in adults, Desloratadine 5 mg did not affect<br />standard measures of flight performance including exacerbation of subjective sleepiness or tasks<br />related to flying.<br />In clinical pharmacology trials, co-administration with alcohol did not increase the alcohol-induced<br />impairment in performance or increase in sleepiness. No significant differences were found in the<br />psychomotor test results between Desloratadine and placebo groups, whether administered alone or<br />with alcohol.</p><p>In patients with allergic rhinitis, Desloratadine was effective in relieving symptoms such as sneezing,<br />nasal discharge and itching, as well as ocular itching, tearing<br />Paediatric population<br />The efficacy of Desloratadine tablets has not been clearly demonstrated in trials with adolescent<br />patients12 through 17 years of age.<br />In addition to the established classifications of seasonal and perennial, allergic rhinitis can<br />alternatively be classified as intermittent allergic rhinitis and persistent allergic rhinitis according to<br />the duration of symptoms. Intermittent allergic rhinitis is defined as the presence of symptoms for<br />less than 4 days per week or for less than 4 weeks. Persistent allergic rhinitis is defined as the<br />presence of symptoms for 4 days or more per week and for more than 4 weeks.<br />Desloratadine was effective in alleviating the burden of seasonal allergic rhinitis as shown by the<br />total score of the rhino-conjunctivitis quality of life questionnaire. The greatest amelioration was seen<br />in the domains of practical problems and daily activities limited by symptoms.<br />Chronic idiopathic urticaria was studied as a clinical model for urticarial conditions, since the<br />underlying pathophysiology is similar, regardless of etiology, and because chronic patients can be<br />more easily recruited prospectively. Since histamine release is a causal factor in all urticarial diseases,<br />Desloratadine is expected to be effective in providing symptomatic relief for other urticarial<br />conditions, in addition to chronic idiopathic urticaria, as advised in clinical guidelines.<br />In two placebo-controlled six week trials in patients with chronic idiopathic urticaria, Desloratadine<br />was effective in relieving pruritus and decreasing the size and number of hives by the end of the<br />first dosing interval. In each trial, the effects were sustained over the 24 hour dosing interval. As with<br />other antihistamine trials in chronic idiopathic urticaria, the minority of patients who were identified<br />as non-responsive to antihistamines was excluded. An improvement in pruritus of more than 50 %<br />was observed in 55 % of patients treated with desloratadine compared with 19 % of patients treated<br />with placebo. Treatment with Desloratadine also significantly reduced interference with sleep and<br />daytime function, as measured by a four-point scale used to assess these variables.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Absorption<br />Desloratadine plasma concentrations can be detected within 30 minutes of administration.<br />Desloratadine is well absorbed with maximum concentration achieved after approximately 3 hours;<br />the terminal phase half-life is approximately 27 hours. The degree of accumulation of Desloratadine<br />was consistent with its half-life (approximately 27 hours) and a once daily dosing frequency. The<br />bioavailability of Desloratadine was dose proportional over the range of 5 mg to 20 mg.<br />In a pharmacokinetic trial in which patient demographics were comparable to those of the general<br />seasonal allergic rhinitis population, 4 % of the subjects achieved a higher concentration of<br />Desloratadine. This percentage may vary according to ethnic background. Maximum Desloratadine<br />concentration was about 3-fold higher at approximately 7 hours with a terminal phase half-life of<br />approximately 89 hours. The safety profile of these subjects was not different from that of the general<br />population.<br />Distribution<br />Desloratadine is moderately bound (83 % - 87 %) to plasma proteins. There is no evidence of<br />clinically relevant medicine accumulation following once daily dosing of Desloratadine (5 mg to 20<br />mg) for 14 days.<br />Biotransformation<br />The enzyme responsible for the metabolism of Desloratadine has not been identified yet, and<br />therefore, some interactions with other medicinal products cannot be fully excluded. Desloratadine<br />does not inhibit CYP3A4 in vivo and in vitro studies have shown that the medicinal product does not<br />inhibit CYP2D6 and is neither a substrate nor an inhibitor of P-glycoprotein.<br />Elimination<br />In a single dose trial using a 7.5 mg dose of Desloratadine, there was no effect of food (high-fat, high<br />caloric breakfast) on the disposition of Desloratadine. In another study, grapefruit juice had no effect<br />on the disposition of Desloratadine.</p><p>&nbsp;</p><p>Renally impaired patients<br />The pharmacokinetics of Desloratadine in patients with chronic renal insufficiency (CRI) was<br />compared with that of healthy subjects in one single-dose study and one multiple dose study. In the<br />single-dose study, the exposure to Desloratadine was approximately 2 and 2.5-fold greater in subjects<br />with mild to moderate and severe CRI, respectively, than in healthy subjects. In the multiple-dose<br />study, steady state was reached after Day 11, and compared to healthy subjects the exposure to<br />Desloratadine was ~1.5-fold greater in subjects with mild to moderate CRI and ~2.5-fold greater in<br />subjects with severe CRI. In both studies, changes in exposure (AUC and Cmax) of Desloratadine<br />and 3-hydroxydesloratadine were not clinically relevant.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Desloratadine is the primary active metabolite of Loratadine. Non-clinical studies conducted with<br />Desloratadine and Loratadine demonstrated that there are no qualitative or quantitative differences in<br />the toxicity profile of Desloratadine and Loratadine at comparable levels of exposure to Desloratadine.<br />Non-clinical data with Desloratadine reveal no special hazard for humans based on conventional<br />studies of safety pharmacology, repeated dose toxicity, genotoxicity, and toxicity to reproduction.<br />The lack of carcinogenic potential was demonstrated in studies conducted with Desloratadine and<br />Loratadine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Tablet Core Containing:<br />1. Dibasic Calcium Phosphate Dihydrate (DC Grade)<br />2. Microcrystalline Cellulose -PH102<br />3. Maize Starch<br />4. Crospovidone NF<br />5. Magnesium Stearate<br />6. Talc<br />Film Coating Containing<br />1. Opadry White 03H28604<br />2. Propylene Glycol<br />3. Purified Water</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not applicable.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years (36 Months)
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p> Do not store above 30&deg;C.<br /> Store in a dry place.<br /> Keep out the sight and reached of children.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Deslor 5mg Film Coated Tablet is packed as Alu-PVC/Aclar blisters containing 20 (2x10) tablets in<br />outer carton with Patient Information Leaflet.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Jamjoom Pharmaceuticals Company
Plot No. ME 1:3, Phase V, Industrial City, Jeddah
Postal address:
P.O. Box 6267
Jeddah 21442, Saudi Arabia.
Tel: 00966-12-6081111
Fax: 00966-12-6081222
E-mail: jpharma@jamjoompharma.com
Website: www.jamjoompharma.com
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                12/2017
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>